Link: #GLP1 #PrimaryCare #NICEGuidance #NHS #Medicaleducation To view or add a comment, sign in CDSCO's move to ban FDCs lacking evidence of added clinical benefit aligns India's regulatory framework with best global practices that prioritize clinical evidence and patient safety, over commercial interests
OTA and aflatoxins were the most common mycotoxins found.[ref] Another study involving 112 ME/CFS patients in Kansas City found that 93% of chronic fatigue patients had mycotoxins in their urine, while none of the healthy control group (n=55) had mycotoxins.[ref] Related article: ME/CFS and Genetics Genes involved in mycotoxin detoxification We are all regularly exposed to mycotoxins at trace levels, and our bodies have ways of getting rid of mycotoxins
Kaisers 2026 formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
Do not change the dose or convert between milligrams, millilitres and syringe units without professional guidance
In 2010, 0.1% of T1D patients were treated with SGLT2 inhibitors, rising significantly to 2.4% in 2023